Prognostic value of E/e' ratio and its change over time in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction in the reperfusion era
Copyright © 2024. Published by Elsevier Ltd..
BACKGROUND: The ratio of early diastolic mitral inflow velocity to mitral annular velocity (E/e') is a prognostic factor in patients with ST-segment elevation myocardial infarction (STEMI). However, data are lacking on long-term outcomes and longitudinal changes in E/e' in patients with preserved left ventricular ejection fraction (LVEF) in the reperfusion era.
METHODS: This is a pre-specified echocardiographic substudy of a randomized controlled trial evaluating the efficacy of beta-blockers in STEMI patients with LVEF ≥40 % after primary percutaneous coronary intervention (PCI). Patients were divided into 2 groups according to E/e' at discharge: ≤14 (normal E/e' group) or > 14 (high E/e' group). The primary outcome was a composite of all-cause death, myocardial infarction, stroke, acute coronary syndrome, and heart failure hospitalization. We also assessed longitudinal changes in E/e' and conducted a landmark analysis using E/e' at 1 year after STEMI.
RESULTS: There were 173 and 38 patients in the normal and high E/e' groups, respectively. During a median follow-up of 3.9 years, the primary outcome occurred in 19 patients (11.0 %) and 10 patients (26.3 %) in the normal and high E/e' groups, respectively. The cumulative incidence of the primary outcome was higher in the high E/e' group than in the normal E/e' group (21.9 % vs. 7.1 % at 3 years; log-rank p = 0.013). E/e' in the high E/e' group decreased over time (p < 0.001), but remained higher than in the normal E/e' group at 1 year after STEMI (13.7 ± 5.3 vs. 8.6 ± 2.3, p < 0.001). E/e' > 14 at 1 year was also associated with poor outcomes (log-rank p = 0.008). A sensitivity analysis using multivariate Cox proportional hazards regression models yielded consistent results.
CONCLUSION: High E/e' at discharge is associated with poor long-term outcomes in STEMI patients with preserved LVEF after primary PCI, which may be explained by persistent high E/e' late after STEMI.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Journal of cardiology - (2024) vom: 14. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Miyake, Makoto [VerfasserIn] |
---|
Links: |
---|
Themen: |
Echocardiography |
---|
Anmerkungen: |
Date Revised 22.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.jjcc.2024.03.002 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369803221 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369803221 | ||
003 | DE-627 | ||
005 | 20240323235337.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240316s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jjcc.2024.03.002 |2 doi | |
028 | 5 | 2 | |a pubmed24n1342.xml |
035 | |a (DE-627)NLM369803221 | ||
035 | |a (NLM)38490639 | ||
035 | |a (PII)S0914-5087(24)00041-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Miyake, Makoto |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prognostic value of E/e' ratio and its change over time in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction in the reperfusion era |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 22.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2024. Published by Elsevier Ltd. | ||
520 | |a BACKGROUND: The ratio of early diastolic mitral inflow velocity to mitral annular velocity (E/e') is a prognostic factor in patients with ST-segment elevation myocardial infarction (STEMI). However, data are lacking on long-term outcomes and longitudinal changes in E/e' in patients with preserved left ventricular ejection fraction (LVEF) in the reperfusion era | ||
520 | |a METHODS: This is a pre-specified echocardiographic substudy of a randomized controlled trial evaluating the efficacy of beta-blockers in STEMI patients with LVEF ≥40 % after primary percutaneous coronary intervention (PCI). Patients were divided into 2 groups according to E/e' at discharge: ≤14 (normal E/e' group) or > 14 (high E/e' group). The primary outcome was a composite of all-cause death, myocardial infarction, stroke, acute coronary syndrome, and heart failure hospitalization. We also assessed longitudinal changes in E/e' and conducted a landmark analysis using E/e' at 1 year after STEMI | ||
520 | |a RESULTS: There were 173 and 38 patients in the normal and high E/e' groups, respectively. During a median follow-up of 3.9 years, the primary outcome occurred in 19 patients (11.0 %) and 10 patients (26.3 %) in the normal and high E/e' groups, respectively. The cumulative incidence of the primary outcome was higher in the high E/e' group than in the normal E/e' group (21.9 % vs. 7.1 % at 3 years; log-rank p = 0.013). E/e' in the high E/e' group decreased over time (p < 0.001), but remained higher than in the normal E/e' group at 1 year after STEMI (13.7 ± 5.3 vs. 8.6 ± 2.3, p < 0.001). E/e' > 14 at 1 year was also associated with poor outcomes (log-rank p = 0.008). A sensitivity analysis using multivariate Cox proportional hazards regression models yielded consistent results | ||
520 | |a CONCLUSION: High E/e' at discharge is associated with poor long-term outcomes in STEMI patients with preserved LVEF after primary PCI, which may be explained by persistent high E/e' late after STEMI | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Echocardiography | |
650 | 4 | |a Left ventricular diastolic function | |
650 | 4 | |a Primary percutaneous coronary intervention | |
650 | 4 | |a ST-segment elevation myocardial infarction | |
700 | 1 | |a Izumi, Chisato |e verfasserin |4 aut | |
700 | 1 | |a Watanabe, Hiroki |e verfasserin |4 aut | |
700 | 1 | |a Ozasa, Neiko |e verfasserin |4 aut | |
700 | 1 | |a Morimoto, Takeshi |e verfasserin |4 aut | |
700 | 1 | |a Matsutani, Hayato |e verfasserin |4 aut | |
700 | 1 | |a Takahashi, Shuichi |e verfasserin |4 aut | |
700 | 1 | |a Ohtani, Yuya |e verfasserin |4 aut | |
700 | 1 | |a Baba, Megumi |e verfasserin |4 aut | |
700 | 1 | |a Sakamoto, Jiro |e verfasserin |4 aut | |
700 | 1 | |a Tamaki, Yodo |e verfasserin |4 aut | |
700 | 1 | |a Enomoto, Soichiro |e verfasserin |4 aut | |
700 | 1 | |a Kondo, Hirokazu |e verfasserin |4 aut | |
700 | 1 | |a Tamura, Toshihiro |e verfasserin |4 aut | |
700 | 1 | |a Nakagawa, Yoshihisa |e verfasserin |4 aut | |
700 | 1 | |a Kimura, Takeshi |e verfasserin |4 aut | |
700 | 0 | |a CAPITAL-RCT Investigators |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of cardiology |d 1996 |g (2024) vom: 14. März |w (DE-627)NLM012655120 |x 1876-4738 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:14 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jjcc.2024.03.002 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 14 |c 03 |